Director, Franchise Portfolio Management - CNS

Azurity Pharmaceuticals is a privately held, specialty pharmaceutical company that focuses on innovative products that meet the needs of underserved patients. As an industry leader in providing unique, accessible, and high-quality medications, Azurity leverages its integrated capabilities and vast partner network to continually expand its broad commercial product portfolio and robust late-stage pipeline. The company’s patient-centric products span the cardiovascular, neurology, endocrinology, gastro-intestinal, institutional, and orphan markets, and have benefited millions of patients. For more information, visit www.azurity.com.

Azurity Pharmaceuticals is proud to be an inclusive workplace and an Equal Opportunity Employer. Azurity's success is attributable to our incredibly talented, dedicated team that focuses on benefiting the lives of patients by bringing the best science and commitment to quality into everything that we do. We seek highly motivated individuals with the dedication, integrity, and creative spirit needed to thrive in our organization.

Brief team/department description:

The Associate Director of Franchise Portfolio Management at Azurity plays a crucial role in strategy development, management, and execution for the franchise product portfolio, supporting the VP of Franchise Portfolio Management.

Principle Responsibilities:

• Gain a strong expertise in the therapy areas overseen by the franchise through targeted research, competitive intelligence, engagement with market and customer insights, and attendance at key conferences.
• Contribute to franchise-level strategic plans, including mature asset management and revenue optimization.
• Drive brand strategy development and execution through each Product Lifecycle Management (PLM) stage, ensuring readiness for launch.
• Manage brand plans, pricing strategies, forecasts and forecast assumptions, target product profiles (TPPs), and P&Ls over the life of products/brands managed by the franchise. Guide launch archetype development and post-launch enhancements, including line extensions and phase-outs.
• Continuously gather and analyze customer insights to refine product and commercial strategies.
• Oversee product enhancements and line extensions after market introduction, and plan for phase-outs and support withdrawal as products reach end-of-life.
• Support Product Lifecycle Management (PLM) process through all stages under the guidance of VP Franchise Portfolio Management, and coordinate with relevant cross-functional teams to meet stage-gate criteria and timelines and recommend product discontinuations when needed.
• Assist in preparing reports, presentations, and recommendations for portfolio reviews and strategic planning sessions.
• Work with the corporate development team to identify, evaluate, and integrate external assets that enhance the internal portfolio and strengthen product offerings.

Qualifications and Education Requirements

• PharmD or PhD or bachelor’s or master’s degree in a relevant field (e.g., Life Sciences, Business Administration) preferred.
• 5+ years of relevant experience with an advanced degree; 10+ years with a bachelor’s degree
• Experience in pipeline or in-line marketing or new products commercialization
• Familiarity with therapeutic areas and pharmaceutical drug development and commercialization.
• Experience conducting primary and secondary market research and developing, discussion guides, target product profiles (TPPs), forecast assumptions for new product ideas.
• Experience in sales forecasting and financial modeling.
• Knowledge of pharmaceutical product lifecycle management and commercialization processes.
• Detail-oriented with strong organizational skills, capable of managing multiple tasks and priorities.

#LI-Hybrid

The California Consumer Privacy Act regulates privacy rights and consumer protection for residents of California, United States. For details, click here.

The General Data Protection Regulation (GDPR) sets guidelines for the collection and processing of personal information from individuals who live in the European Union (EU).